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A B S T R A C T
Acute kidney injury (AKI) is a complex, frequent and serious clinical problem with high rate of mortality. Therefore
there is a serious need for early detection of AKI, with a tendency to detect early stage – RISK dut to start with therapy as
soon as possible and prevent irreversible changes in renal function. Study’s purposes were to explore the rhythm of urine
neutrophile gelatinase associated lipocalin (urine NGAL) concentration changes before and after cardiovascular surgery
and compare results of urine NGAL values with results of serum creatinine and creatinine clearance as main diagnostic
indicators of renal function in order to define role of urine NGAL biomarker in early diagnosis of acute kidney injure. In
the prospective clinical study 150 cardiovascular surgery patients were included. Basal value and concentration of urine
NGAL were tested 3, 6 and 12 hours after cardiovascular surgery, and concentration of serum creatinine was tested once
per day first three days after surgery. Also creatinine clearance value was calculated according to Cockrof-Goult formula.
After above mentioned, rate of acute kidney injure was estimated according to RIFLE criteria. The study results showed
that the value of urine NGAL was elevated above cutt-off after cardiac operation in a group of patients who developed
AKI (defined according to RIFLE criteria). There were statisticaly significant difference between all four measerments
(p<0.05). There were also moderate positive correlation (0.500 and 0.502) between urine NGAL values and percentage
difference of serum creatinine and creatinine clearence. All that indicate that higer values of urine NGAL are followed by
higher percentage difference of serume creatinine and creatinine clearence. By using of automated urine NGAL test de-
tection of acute kidney injure is posible 24–48 hours earlier comparing with actual results acquired by determination of
serum creatinine concentration. The results of this study will indicate urine NGAL as a reliable biomarker of early acute
kidney injure. A combination of early and late markers of kidney damage (urine NGAL, serum creatinine) can greatly
contribute to better control the outcome of all those who are a risk group for the development of AKI.
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Introduction
Acute kidney injury occurs as a complication in ap-
proximatelly 2–5% hospitalised patients, whereas up to
30% of admitted patients in intensive care units (ICU)
develops this complication1. Mortality associated with
AKI is appoximatelly 50%. Percentage of survival is con-
siderably lower in patients who developed acute kidney
injury compared to the patients who have not experi-
enced such type of injury. Approximatelly 50% of patients
who survive an acute kidney injury, develope subclinical
impairment of kidney function. The kidney function is
never recovered in approximatelly 5% of patients and
it requires prolonged dialysis or transplantation treat-
ment2. Early diagnostics of initial kidney injury and
prevention of further effects of detrimental factors is of
immense importance. In addition to specific clinical indi-
cators, urin analysis and determination of kidney failure
index, very important AKI indicator can be obtained
through laboratory findings. In this regard, the serial se-
rum creatinine measurements have been used as the
main AKI diagnostic indicator for the last 50 years3. The
practice to date indicates that the use of serum creati-
nine in detecting of early kidney failure has been limited
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because it dependens on a number of extra-renal factors.
Therefore, there is a justified need to develop and apply
new biomarkers which will contribute to quality and reli-
able diagnostics of acute kidney injury, in order to achieve
timely therapeutic effects. Such biomarker should be
specific and easily measurable. It should also provide re-
producible results, correlate with severity of condition,
indicate the severity of renal injury even when no typical
clinical signs are present, and indicate, in timely manner,
the need to introduce therapy4. Measurement of urinary
NGAL levels, as a marker for ishemic and nephrotoxic
injury to renal parenchyma, anticipates the possibility to
identify, more precisely, the occurrence and early diagno-
sis of acute kidney injury which is particularly important
in monitoring and treatment following the cardiovascular
surgeries, where AKI development is mostly combined
with ischemic impairment of renal perfusion or reduc-
tion of renal reserve5–7. The studies show that increase of
NGAL concentrations occurrs 24–48 hours earlier in
comparison with the increase of serum creatinine after
the cardiac surgery8.
The objective of this study was to investigate dynam-
ics of urine NGAL changes in patients before and after
cardiovascular surgeries, to compare the obtained urine
NGAL values with serum creatinine and creatinine clear-
ance values, being the main diagnostic indicators of renal
function, and to determine whether the urine NGAL has




Prospective clinical trial was conducted in May 2010–
July 2012 period, in the Clinical Center of Sarajevo Uni-
versity, in an intensive care unit (ICU) of the Cardiac
Surgery Clinic. The trial included 150 patients above the
age of 18 (both genders), who underwent cardiovascular
surgery, were admitted to intensive care unit and hospi-
talised for more than 24 hours. The patients with the ex-
isting chronic renal insufficiency, the chronic hemodialy-
sis patients, patients receiving peritoneal dialysis, patients
with existing peripheral vascular diseases, patients suf-
fering from diabetes mellitus, patients who used nephro-
toxic drugs prior to the study (aminoglycosides, non-
-steroidal anti-inflammatory drugs, etc.), patients under
the 18 years of age, hospitalised for less than 24 hours,
patients with confirmed infection of upper urinary tract
or hematuria, were not included in the study. Medical re-
cords of patients were used (history), which gave an in-
sight to laboratory, clinical and demographic data. Urine
samples were collected from each patient to determine
NGAL concentration in urine whereas blood samples
were taken to determine serum creatinine and urea lev-
els. Creatinine clearance was calculated using the Cock-
croft-Gault formula (equation). The laboratory findings
of patients with confirmed normal preoperative kidney
status were used to assess development of AKI in postop-
erative period. The former researches show that moni-
toring of daily diuresis in patients, following the cardiac
surgery, is not relevant in assessing the development of
acute kidney injury due to excessive use of diuretics in
treatment of these patients. Thus, the use of this param-
eter in the mentioned group of patients is not considered
relevant. Due to the same reason, the mentioned param-
eter was not taken into consideration.
Methods
Upon admission, basal renal function was determined
for each patient, based on the data on serum creatinine
concentration and calculated creatinine clearance, which
were obtained prior to the surgery. During the hospitali-
sation, all patients were evaluated through collection
and analysis of the monitored parameters. Urine NGAL
concentration was measured 3, 6, and 12 hours after the
completion of surgical procedure, whereas serum creati-
nine was measured once a day during the first three days
following the surgery. Measurement of NGAL and creati-
nine concentrations was conducted using the automated
immuno-biochemical analyser, the so called Architect
ci8200, of company Abbott Laboratories. In order to mea-
sure urine NGAL concentration, the Chemiluminescent
Microparticle Immunoassay Technique (CMIA) was ap-
plied. The reagents, used in biochemical reaction, con-
tain designed antibodies which may bind to epitopes on
NGAL molecule. Architect NGAL test had a functional
sensitivity <2 ng/mL and total coefficient of variation
(CV) less than 5%. NGAL cutt-of value is 100 ng/mL9. Ac-
cording to Bennet’s modified RIFLE Classification for
AKI, conducted against the value of NGAL in urine8,
NGAL values <100 ng/mL are considered normal, values
ranging from 101–200 ng/mL are considered an early sta-
ge of AKI (Risk – R), values ranging from 201–300 ng/mL
correspond to AKI Injury stage (I), whereas the values
>300 ng/mLl correspond to AKI Failure stage (F). The
urine sample intended for measurement of NGAL con-
centration was sent to laboratory for analysis, immedi-
ately after having been collected. When it was necessary
to postpone the testing, the sample was stored in refrig-
erator at 2–8 °C for the period of 7 days, of for the longer
period at –70 °C. Serum creatinine concentration was
measured by modified kinetic Jaffeove reaction (method)
on Laser Nephelometer BN II. Serum urea concentration
was measured by the standard ureasis laboratory
method (modified Talke and Schubert enzymatic proce-
dure) on Architect ci8200. Determination of kidney func-
tion following the surgery was conducted based on the
monitoring of daily changes of serum creatinine. Creati-
nine clearance (eCCr) was assessed using the Cockcroft-
-Gault formula10. The normal renal function is deter-
mined by the value of creatinine clearance ³90 mL/min.
Creatinine clearance was calculated using the Cockcroft-
-Gault formula:
eCCr=
(140 – years) x body weight (kg) (x 0,85 for women)
72 x serum creatinin (mmol/L)
Diagnosis and assessment of the severity of acute kid-
ney injury was conducted in line with RIFLE criteria11,12,
where an increase in serum creatinine ³26.2 mmol/L from
baseline within 24 hours or 1.5-fold increase of serume
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creatinine from baseline, or decrease of creatinine clear-
ance by 25% from baseline for minimum 3 days, i.e.
diuresis less than od 0.5 mL/kg/hour for the period ex-
ceeding 6 hours13, is considered an early stage of acute
kidney injury, according to this classification. Application
of RIFLE criteria enables the patients to be stratified
with regard to various levels of their kidney injury based
on severity (risk, injury, failure) and an outcome (loss,
end stage).
Statistics
The statistical methods used for data processing were
as follows: average value (X – arithmetic mean), standard
deviation (SD), median (mean value), minimum value,
maximum value, and 25th–75th percentiles. Distribution
values of analysed variables were assessed using the
D’Agostino-Pearson test. The dependent samples Stu-
dent’s t test was used to assess the differences within the
groups. Friedman test (F) »double analysis of variance by
ranks« was conducted to assess the differences between
the results obtained within the group. One-way analysis
of variance was applied in the analyses of results ob-
tained through repeated measurements which satisfied
the normal distribution conditions. The correlation range
was assessed using Spearman’s rank correlation coeffi-
cient. Accepted statistical significance was p<0.05. Sta-
tististical analyses were conducted in Med Calc statisti-
cal software for Windows, version 12.2.1.0. (MedCalc
Software, Mariakerke, Belgium).
Results
The study included 150 patients, with the average age
of 59.46±10.14, average body weight 84.36 kg±14.74
and average height 172.53 cm±8.18. Out of total number
of respondents, 108 were males, while 42 respondents
were females. Based on preoperative serum creatinine
concentrations, as well as the values obtained after the
first, second and third day after surgery, and in line with
RIFLE classification of acute kidney injury, the patients
were stratified in the group of respondents with no AKI
(normal findings), risk group (R), injury group (I) and
failure group (F) (Table 1). The largest number of pa-
tients with normal findings was identified on the first
day after the surgery (144), whereas the largest number
of patients who developed an injury was identified on the
third day of postoperative measurement (14). Median
value of urine NGAL indicates elevation of postoperative
urine NGAL in all three measurements, i.e. 3, 6 and 12
hours after the surgery (5.50 ng/mL vs. 6.45 ng/mL vs.
9.80 ng/mL), compared to preoperative values (3.65 ng/ml)
in patients who developed AKI, defined in line with the
RIFLE criteria (Table 2). The results of Friedman test
(F) demonstrate a significant difference in urine NGAL
concentrations in four different periods (before the sur-
gery, and than three, six and twelve hours after the sur-
gery), (F (3, 450, N=600)=72.0655, p<0.001) in all patients
who developed AKI. Correlation analysis was conducted
to assess NGAL values in all measurements (three, six
and twelve hours after the surgery) and percentage dif-
ferences in serum creatinine values. The moderately pos-
itive correlations of significant importance were obtained,
which indicate that higher NGAL values correspond to
more considerable percentage differences in serum crea-
tinine. The most considerable correlation was confirmed
between urine NGAL values obtained 12 hours after the
surgery and percentage difference between serum crea-
tinine values obtained in the first and the fourth measure-
ment (Table 3). According to urine NGAL cut-off value of
100 ng/mL, it was established that urine NGAL values
were elevated in 21 respondents, out of which the major-
ity had values ranging from 101 to 200 ng/ml in all three
measurements. The largest number of respondents with
elevated urine NGAL values was reported 12 hours after
the surgery (Table 4, Figure 1). With regard to the above
mentioned, it is evident that, using the test to determine
urine NGAL, it is possible to identify acute kidney injury
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TABLE 1




First day Second day Third day
Without of AKI 144 137 130
Risk (R) 5 8 6
Injury (I) 1 4 12
Failure (F) 0 1 2
Total 150 150 150
TABLE 2
NGAL VALUES IN THE URINE BEFORE AND AFTER SURGERY
NGAL1 (ng/mL) NGAL2 (ng/mL) NGAL3 (ng/mL) NGAL4 (ng/mL)
N 150 150 150 150
X±SD 7.09±9.49 30.50±91.38 27.40±61.20 37.77±91.98
Median 3.65 5.50* 6.45† 9.80§
95% CI for Median 2.50–5.00 3.80–7.14 5.25–8.19 7.01–11.29
IQR 8.50 3.90 4.40 17.82
NGAL1 – Urine NGAL preoperative value; NGAL2 – Urine NGAL value three hours after surgery; NGAL3 – Urine NGAL value six
hours after surgery, NGAL4 – Urine NGAL value twelve hours after surgery, IQR – Interquartile range; *p<0.05 difference between
NGAL2 and NGAL1; †p<0.05 difference between NGAL3 and NGAL1; §p<0.05 difference between NGAL4 and NGAL1
24–48 hours earlier compared to dynamics of changes of
serume creatinine concentrations. If we use the results
obtained by measuring serum creatinine, the largest
number of positive results is obtained only 48 hours later,
and these results, according to RIFLE classification, fall
under the Injury group (I).
Discussion
The acute kidney injury constitutes a complex, fre-
quent and serious problem. It should be emphasised that
the AKI-related mortality remains 50% and it has not
seen significant changes over the course of the past 30
years. The percentages are particularly high in intensive
care units, ranging from 46% to 88%. Thus far, the detec-
tion and differential diagnosis have been based on a sin-
gle marker – serum creatinine. Unfortunately, serum
creatinine concentration reveals no changes until a sig-
nificant injury or loss of nephron function occurs. Cher-
tow et al demonstrated that serum creatinine elevation
of ³0.3 mg/dL in hospitalized adults is directly associated
with the fourfold increase in the risk of morbidity, even
in patients with controlled diabetes, heart condition and
factors such as age of the patient15. The RIFLE and
AKIN criteria have been extensively validated in more
then 550 000 patients, it was demonstrated that serum
creatinine elevation of 50% is directly associated with in-
crease of mortality in patients16. It is for these reasons
that various recently conducted studies analysed new
biomarkers. The studies investigate and seek to identify
a biomarker which would be characterized by increased
production and exertion in damaged cells, while the pro-
duction and exertion would be negligible in healthy cells.
Elevated concentration of such biomarker should occur
during the early phase in which the injury remains re-
versible and it should be proportional with the severity of
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TABLE 3
CORRELATION BETWEEN VALUE OF URINE NGAL AND THE PERCENTAGE DIFFERENCES OF SERUM CREATININE IN THE
DEFINED MEASUREMENT PERIODS
NGAL2 (ng/mL) NGAL3 (ng/mL) NGAL4 (ng/mL)
r r r
Percentage difference of creatinine 1 0.399* 0.353* 0.286**
Percentage difference of creatinine 2 0.438* 0.428* 0.469*
Percentage difference of creatinine 3 0.468* 0.478* 0.500*
NGAL1 – urine NGAL preoperative value, NGAL2 – urine NGAL value three hours after surgery, NGAL3 – urine NGAL value six
hours after surgery, NGAL4 – urine NGAL value twelve hours after surgery; Percentage difference of creatinine 1 – between value of
serum creatinine preoperative and first postoperative day; Percentage difference of creatinine 2 – between value of serum creatinine
preoperative and second postoperative day; Percentage difference of creatinine 3 – between value of serum creatinine preoperative and
third postoperative day
r=coefficient of correlation; *p<0.0001; **p=0.0004
TABLE 4
PATIENT CLASSIFICATION ACCORDING TO THE VALUE OF URINE NGAL IN THE DEFINED MEASUREMENT PERIODS
NGAL ng/ml Preoperative value (N) 3 hours after surgery (N) 6 hours after surgery (N) 12 hours after surgery (N)
<100 150 139 134 130
101–200 0 6 14 16
201–300 0 1 1 1
>300 0 4 1 3
Total 150 150 150 150
N – number of patients; normal findings of urine NGAL 0–100 ng/mL, risk stage: urine NGAL 101–200 ng/mL, injury stage: urine




























Fig. 1. Patient distribution according to RIFLE criterion in rela-
tion to the value of urine NGAL.
the injury; while the reduction in concentration should
correlate with the absence of kidney injury. The dynamic
changes in concentration should also enable monitoring
of the therapeutic effect. The biomarker should be such
that it is simple to determine by a non-invasive method.
In addition, it should be easily measurable, associated
with the pathophysiology of the condition and progno-
stically relevant. Our study followed the changes in urine
NGAL concentration in patients who underwent cardiac
surgery. The advantage to determining NGAL in urine is
that the samples are collected non-invasively and the
likelihood of interference with other protein molecules is
reduced, while the diagnostic method itself is performed
quickly. During cardiac surgery the most frequent mech-
anism of AKI is renal vasoconstriction and microvascular
injury, leading to prolonged renal ischemia, renal hypo-
perfusion and ischemic reperfusion injury17. The reason
for selecting this particular group of patients is that it is
possible to determine the biomarker immediately after
the surgery and to monitor possible development of AKI.
Availability of adequate and well substantiated support-
ing documentation constitutes an additional reason in
this regard. Our study verified acute kidney injury (AKI)
in 14% of patients monitored after cardiovascular surger-
ies. We have confirmed that NGAL is simple to measure
and that the excretion of NGAL is heightened in case of
injury, while the excretion seen in healthy cells is negligi-
ble (control group). Elevation of urine NGAL concentra-
tion was measured already three hours after surgery,
while the most significant correlation between urine
NGAL value and prercentage difference of serum crea-
tinine was measured 12 hours after surgery. Results of
this study demonstrate that elevation of urine NGAL
concentration occurs 24–48 hours earlier as compared to
serum creatinine, the previously used biomarker, which
is in line with the studies conducted for the same pur-
poses8,18,19. The results suggest that it is possible to iden-
tify early stage of acute kidney injury based on single
time point measurements of NGAL conducted in the pe-
riod between 3 and 12 hours, as opposed to serial mea-
surements of serum creatinine, that do not allow for
monitoring of sudden changes in renal function. Accord-
ing to the results obtained, it is possible to conclude that
urine NGAL is the marker for early detection of AKI,
while serum creatinine is the marker for late detection
which allows for monitoring of further course of develop-
ment, recovery or impairment of renal function. The
study reconfirmed the usefulness of application of RI-
FLE classification. In addition, it reconfirmed that by
combining the biomarkers it is possible to achieve signifi-
cant improvements as regards diagnosis, monitoring and
therapy of AKI. The respondents monitored according to
the risk group criteria exhibited significantly increased
risk to develop injury and experience impaired renal
function. A clear difference between all four measure-
ments of urine NGAL was recorded. The difference be-
tween the baseline values and the values measured after
a surgery in patients who developed AKI was particularly
significant. The recorded difference ranged from being
10 to 100 times higher, whereby the urine NGAL clearly
indicates the early nephron impairment at the stage
when the changes are reversible and it is possible to in-
tervene in due time and achieve effects in terms of reduc-
ing the morbidity and mortality rates. Majority of studies
conducted thus far demonstrated that NGAL is closely
associated with AKI in patients with normal renal func-
tion prior to surgery and glomerular filtration value of
³60 ml/min20. Further research is needed, particularly in
the group of patients with coexisting pathology, such as
chronic kidney disease, cardiac decompensation and car-
diorenal syndrome, systemic infections, systemic inflam-
matory conditions and malignancy. In conclusion, results
of the study indicate significant positive correlation be-
tween urine NGAL concentration and serum creatinine
values, i.e. creatinine clearance. The highest correlation
was recorded 12 hours after surgery. Therefore, we may
conclude that the factor of time plays an essential role in
detection of acute kidney injury. Undoubtedly, there is a
need for early detection of AKI, aiming at detection of
the earliest RISK stage, which allows for timely interven-
tion and prevention of irreversible changes in renal func-
tion, as well as differential diagnosis of AKI.
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ZNA^AJ ODRE\IVANJA URINARNOG LIPOKALINA UDRU@ENOG SA NEUTROFILNOM
GELATINAZOM U RANOJ DETEKCIJI AKUTNOG BUBRE@NOG O[TE]ENJA
S A @ E T A K
Akutno bubre`no o{te}enje (ABO, eng. AKI) je kompleksan, ~est i ozbiljan klini~ki problem, sa visokom stopom
mortaliteta. Zbog toga postoji ozbiljna potreba za detekcijom ABO, s namjerom da se otkrije u ranoj, RISK fazi – kako bi
se sa terapijom po~elo {to je prije mogu}e te kako bi se sprije~ile nepovratne promjene bubre`ne funkcije. Svrha studije
bila je da se ispita dinamika promjena koncentracija lipokalina udru`enog sa neutrofilnom gelatinazom u urinu (urin-
ski NGAL) prije i nakon kardiovaskularne operacije te da se rezultati urinarnog NGAL-a usporede sa rezultatima
serumskog kreatinina i klirensa kreatinina kao glavnih dijagnosti~kih indikatora bubre`ne funkcije kako bi se utvrdila
uloga biomarkera u vidu urinarnog NGAL-a u ranoj dijagnozi akutnog bubre`nog o{te}enja. Prospektivnom klini~kom
studijom bilo je obuhva}eno 150 pacijenata podvrgnutih kardiovaskularnim operativnim zahvatima. Osnovna (po~et-
na) vrijednosti i koncentracija urinarnog NGAL –a testirane su 3, 6 i 12 sati nakon kardiovaskularne operacije, a kon-
centracija kreatinina u serumu testirana je jednom dnevno, tijekom prva tri dana nakon operacije. Tako|er, vrijednost
klirensa kreatinina ra~unata je prema Cockrof-Goult formuli. Nakon gore navedenog, stopa akutnog bubre`nog o{te-
}enja procijenjena je u skladu sa RIFLE kriterijima. Rezultati studije su pokazali da se vrijednost urinarnog NGAL-a
pove}ala iznad grani~ne tj. pra`ne (eng. cut-off) vrijednosti nakon kardiokirur{ke intervencijie u grupi pacijenata kod
kojih se javilo AKI (definirano prema RIFLE kriterijima). Izme|u sva ~etiri mjerenja postojala je statisti~ki zna~ajna
razlika (p<0.05). Postojala je i umjereno pozitivna korelacija (0,500 i 0,502) izme|u vrijednosti urinarnog NGAL-a i
procentualne razlike kreatinina u serumu i klirensa kreatinina. Sve ovo ukazuje da su vi{e vrijednosti urinarnog NGAL-a
pra}ene ve}im procentualnim razlikama serumskog kreatinina i klirensa kreatinina. Kori{tenjem automatiziranog testa
za urinarni NGAL, akutno bubre`no o{te}enje mogu}e je detektirati 24–48 sati ranije u pore|enju sa stvarnim rezul-
tatima dobivenim odre|ivanjem koncentracije serumskog kreatinina. Rezultati ove studije }e pokazati da je urinarni
NGAL pouzdan biomarker za rano akutno bubre`no o{te}enje. Kombinacija ranih i kasnih markera bubre`nog o{te-
}enja (urinarni NGAL, serumski kreatinina) mo`e u velikoj mjeri doprinijeti boljoj kontroli ishoda za sve one koji spa-
daju u rizi~nu grupu za pojavu AKI.
